JAPhA Practice Innovations最新文献

{"title":"Pharmacists’ perspectives on psilocybin in Canada","authors":"Elizabeth Sugiarto,&nbsp;Rebecca Leung,&nbsp;Jamie Yuen","doi":"10.1016/j.japhpi.2023.100003","DOIUrl":"10.1016/j.japhpi.2023.100003","url":null,"abstract":"<div><h3>Background</h3><p>Psilocybin is the main psychoactive component of a naturally occurring psychedelic organism commonly referred to as “magic mushrooms.” Existing literature demonstrates beneficial neurologic effects in treatment-resistant depression, cancer-associated depression and anxiety, and substance use. The evidence base for psilocybin use is on the rise with the U.S. Food and Drug Administration owing to a resurgence in clinical research. As such, pharmacists need to be adequately equipped to navigate questions from consumers and care providers. There is currently no literature describing pharmacists’ perspectives on psilocybin. Evaluating pharmacists’ knowledge, experiences, and opinions about psilocybin may yield beneficial and applicable data to develop educational programs and clinical tools and guide psilocybin policy making.</p></div><div><h3>Objective</h3><p>The objective of this study was to evaluate the interest and opinions of pharmacists on psilocybin as an emerging therapeutic option.</p></div><div><h3>Methods</h3><p>Licensed pharmacists in Canada were invited to participate in an anonymous, online, 44-item survey aimed at evaluating pharmacists’ experiences, knowledge, and attitudes toward psilocybin. Recruitment for the study was done through multiple Canadian pharmacy association newsletters and via LinkedIn.</p></div><div><h3>Results</h3><p>Results showed that 73% of pharmacists lacked formal education about psilocybin. Forty percent of pharmacists had conversations about psilocybin less than once a month whereas 60% of pharmacists have never received questions about psilocybin. Furthermore, pharmacists are not comfortable with their knowledge with making recommendations (75%), monitoring (57%), or recommending doses of psilocybin (64%) to patients.</p></div><div><h3>Conclusion</h3><p>Pharmacists are open to embracing a role in psilocybin therapy and dispensing. Creation of clinical practice guidelines and increased accessibility to education materials are necessary to supplement pharmacists’ knowledge on psilocybin and improve their confidence when advising patients.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 2","pages":"Article 100003"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969023000039/pdfft?md5=4a43d162f6c9858fdb8e155770b69da7&pid=1-s2.0-S2949969023000039-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135565125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of pharmacist-led vaccine assessment and patient counseling on unmet vaccination needs in the community pharmacy setting","authors":"Ryan Lilly,&nbsp;Linda Dang,&nbsp;Jordan Frangello,&nbsp;Denise Roque,&nbsp;Yifei Liu","doi":"10.1016/j.japhpi.2023.100004","DOIUrl":"10.1016/j.japhpi.2023.100004","url":null,"abstract":"<div><h3>Objective</h3><p>Community pharmacists play an important role in administering vaccines, and a vaccine assessment form (VAF) can be incorporated into the workflow of a community pharmacy. The objective of this study was to evaluate the impact of implementing a VAF combined with pharmacist-led patient counseling on unmet vaccination needs in a community pharmacy setting.</p></div><div><h3>Methods</h3><p>The VAF was a pre-existing questionnaire developed by Walgreen Co (Deerfield, IL) based on the recommendations of the Centers for Disease Control and Prevention. Inclusion criteria were English-speaking patients older than 18 years who visited the pharmacy for at least one vaccine during a 6-month period and completed the VAF. Five pharmacists provided immunization education, determined unmet vaccination needs, and provided individualized patient counseling. Five outcomes were documented: (1) the number of unmet vaccination needs identified, (2) vaccines received in the same visit at the pharmacy, (3) a vaccination appointment for a later date at the pharmacy, (4) a referral was made, and (5) refusal by patients for further action. Descriptive statistics and phi coefficients were used for data analysis.</p></div><div><h3>Results</h3><p>A total of 133 patients visited the pharmacy to receive at least one vaccine and completed the VAF. Pharmacists identified 126 unmet vaccination needs, and the most common ones were for influenza, Tdap, PPSV23, and herpes zoster. The most common outcome was referrals, and the most common reason for delaying a vaccine was cost. Phi coefficients indicated statistically significant associations between identified unmet vaccination needs and referrals across vaccine types.</p></div><div><h3>Conclusion</h3><p>A VAF combined with pharmacist-led patient counseling addressed unmet vaccination needs. In addition, pharmacists made referrals to close immunization gaps.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 2","pages":"Article 100004"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969023000040/pdfft?md5=a32f4b1881da3e1fcf6d2e108971ceba&pid=1-s2.0-S2949969023000040-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135515813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Medication discrepancies across care transitions and the role of pharmacy technicians: A retrospective chart review","authors":"Samantha Liaw,&nbsp;Kristal Ragbir-Toolsie,&nbsp;Rubiya Kabir,&nbsp;Sebastian Choi,&nbsp;Kayla Finuf,&nbsp;Colm Mulvany,&nbsp;Gisele Wolf-Klein,&nbsp;Judith Beizer,&nbsp;Liron Sinvani","doi":"10.1016/j.japhpi.2024.100009","DOIUrl":"10.1016/j.japhpi.2024.100009","url":null,"abstract":"<div><h3>Background</h3><p>After hospitalization, older adults are increasingly discharged to postacute care facilities such as skilled nursing facilities (SNFs). Medication reconciliation and obtaining the best possible medication history (BPMH) are key components of medication management for care transitions and essential for preventing medication errors and adverse drug events.</p></div><div><h3>Objective</h3><p>This study aimed to assess medication discrepancies across care transitions after a Certified Pharmacy Technician (CPhT) obtains the BPMH on hospital admission.</p></div><div><h3>Methods</h3><p>Single-center, retrospective chart review and included adults ≥ 18 years admitted to the medicine service and discharged to a SNF between November 2016 and June 2017. Medication lists were evaluated for discrepancies across 3 transitions: hospital admission to hospital discharge (Time I), hospital discharge to SNF admission (Time II), and SNF admission to SNF discharge (Time III). Discrepancies were categorized by medication class, type of discrepancy, and whether it was potentially intentional or unintentional.</p></div><div><h3>Results</h3><p>In 127 patients, the average age was 83.3 (SD 9.16), 61% (n = 77) were female, and 67% (n = 85) were white. Median hospital length of stay (LOS) was 6 days (interquartile range [IQR] 4-10) and SNF LOS 21 days (IQR 15-30). Across 381 transitions, 6322 medications were reviewed, and 2602 discrepancies identified. The total number of medication discrepancies was 1034 (Time I), 687 (Time II), and 881 (Time III), respectively. All patients had at least one medication discrepancy. The average number of potentially unintentional discrepancies per patient at each transition was 0.14, 0.2, and 0.16, respectively. The most common discrepancy type was omissions (39%), and the highest number of discrepancies in the potentially intentional and unintentional discrepancy groups was gastrointestinal (21%) and cardiovascular medications (24%), respectively.</p></div><div><h3>Conclusion</h3><p>Medication discrepancies are common across all care transitions. Future studies are needed to evaluate the role of CPhT in obtaining the BPMH on hospital admission for reducing medication discrepancies across the continuum of care.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 3","pages":"Article 100009"},"PeriodicalIF":0.0,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969024000022/pdfft?md5=a9df89222cceaf4bae3f9fbdc62661fd&pid=1-s2.0-S2949969024000022-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140406750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of pharmacist involvement in multidisciplinary home visits in a primary care–based management services organization","authors":"Andrea Bush,&nbsp;Tina Benny,&nbsp;Mekaliah Creese,&nbsp;Genevieve Hale,&nbsp;Erika Zwachte,&nbsp;Devada Singh-Franco,&nbsp;Dana Holger","doi":"10.1016/j.japhpi.2024.100008","DOIUrl":"10.1016/j.japhpi.2024.100008","url":null,"abstract":"<div><h3>Background</h3><p>Health care delivery has shifted from fee-for-service to value-based models, allowing pharmacists to integrate within value-based organizations to improve patient outcomes. Although previous studies describe pharmacist involvement in value-based office settings, limited knowledge exists on pharmacist integration in multidisciplinary home visits in a value-based setting.</p></div><div><h3>Objectives</h3><p>This study aimed to describe the integration of pharmacists into multidisciplinary chronic care management (CCM) home visits involving paramedics within a primary care–focused value-based setting. The primary objective is to identify the types and frequency of medication-related problems (MRPs) identified by pharmacists during home visits. The secondary objectives are to determine the number and types of recommendations made to and accepted by providers and patient satisfaction with the pharmacist during the home visit.</p></div><div><h3>Methods</h3><p>Primus Health, a primary care–focused management services organization, integrated pharmacists in CCM home visits. Two ambulatory care pharmacy residents and one clinical pharmacist conducted home visits from January to May 2023 to complete medication reconciliation, identify MRPs, and provide pharmacy support services for patients and providers. A password-protected database was built for data collection and analysis. The data are presented in aggregate.</p></div><div><h3>Results</h3><p>Twenty-one visits involving 15 patients were conducted and 77 MRPs were identified. The most common MRPs were nonadherence (11.6%), laboratory monitoring needed (11.6%), and overdue vaccination (11.6%). Twenty-three of 36 recommendations (63.9%) made to providers were accepted, leading to a therapeutic change. Commonly accepted recommendations were decreasing dose (21.7%), medication deprescription (21.7%), and ordering of laboratory tests (21.7%). All patients agreed or strongly agreed that they were satisfied with the pharmacist-provided care during the home visit.</p></div><div><h3>Conclusions</h3><p>Integration of pharmacists into multidisciplinary CCM home visits led to the resolution of MRPs and demonstrated a potential need for enhanced clinical pharmacy services for home care patients in primary care–focused value-based settings.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 2","pages":"Article 100008"},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969024000010/pdfft?md5=eef91e912e5f91cda239da2140b4ecaf&pid=1-s2.0-S2949969024000010-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139633328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Permissionless innovation in the pharmacy business model: The case for the membership pharmacy model","authors":"Kenneth C. Hohmeier,&nbsp;Phil Baker,&nbsp;Ethan Lobo","doi":"10.1016/j.japhpi.2023.100007","DOIUrl":"10.1016/j.japhpi.2023.100007","url":null,"abstract":"<div><h3>Background</h3><p>There continue to be calls to move away from traditional “fee for service” health care models in favor of patient-centered, value-based models. Concurrent with national efforts, grassroots innovation with novel practice change models are developing at the local level and holds similar potential to transform the pharmacy practice model. One of these innovative models, the membership pharmacy model, may be the least dependent on existing barriers to practice transformation because it is centered on the sale of services rather than products.</p></div><div><h3>Objective</h3><p>To discuss the difference between volume-based and value-based pharmacy models, focusing on how these models impact prescription adherence and patient outcomes. Application of the value-based pharmacy model will be described in the context of Good Shepherd Pharmacy located in Memphis, TN.</p></div><div><h3>Case Summary</h3><p>The volume-based model is centered on prescription fulfillment, with pharmacies incentivized to maximize the number of prescriptions filled. Conversely, the value-based model treats prescription fulfillment as an expense and emphasizes medication adherence as the primary goal. This shift in focus leads to a radical change in the pharmacy’s business model, aligning economic incentives with patients’ best interests. In the value-based model, pharmacies operate on a membership or subscription basis, where revenue is generated through recurring membership fees instead of individual prescription fills. This encourages pharmacies to manage prescription fulfillment efficiently and helps patients reduce their prescription burden, ultimately improving their bottom line.</p></div><div><h3>Practice Implications</h3><p>The value-based pharmacy model is distinguishable from the volume-based model in several aspects. In the value-based model, prescription fills are considered an expense rather than a profit center, and the inventory model shifts from “Just-in-Case” to “Just-in-Time.” Medication synchronization of patients’ refills is a key feature of the value-based model, as it reduces operational costs and maximizes profit per patient. Key performance indicators also shift from being product-centric to patient-centric and reward the organization for improving adherence.</p></div><div><h3>Conclusion</h3><p>The value-based pharmacy model represents a significant departure from traditional pharmacy practices. By incentivizing pharmacies to promote medication adherence and focus on long-term customer relationships, this model has the potential to improve patient outcomes. Further research is needed to study the model’s impact across different settings and patient populations, financial sustainability, and means of spread and scale.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 2","pages":"Article 100007"},"PeriodicalIF":0.0,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969023000076/pdfft?md5=7e585f5a9a9976db320142dfd4ce705a&pid=1-s2.0-S2949969023000076-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139020752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Utilizing pharmacists for billable services related to disease state management","authors":"Kristen N. Pierce,&nbsp;Lakedra White,&nbsp;Chelsea A. Keedy","doi":"10.1016/j.japhpi.2023.100006","DOIUrl":"https://doi.org/10.1016/j.japhpi.2023.100006","url":null,"abstract":"<div><p>Pharmacists are uniquely trained to optimize pharmacotherapy regimens for chronic disease states such as type 2 diabetes as part of an interdisciplinary health care team. Although pharmacists can enter into collaborative practice agreements (CPAs) with physicians that allow them to adjust pharmacotherapy, it is difficult to align these agreements with billable services to sustain pharmacists’ salaries in the primary care setting. Although pharmacists cannot bill directly, they can participate in certain billable services under varying levels of provider supervision. Services such as chronic care management, remote patient monitoring, and continuous glucose monitoring specifically allow for pharmacist participation in care and present opportunities to link CPAs to billable care.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 1","pages":"Article 100006"},"PeriodicalIF":0.0,"publicationDate":"2023-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969023000064/pdfft?md5=a94d32ec8a30c78b2008efbe885cea05&pid=1-s2.0-S2949969023000064-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138557882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diabetes technology: Continuous glucose monitoring and the role of ambulatory care pharmacists","authors":"Ravi Patel,&nbsp;Rebecca Schoen,&nbsp;Kathryn Litten","doi":"10.1016/j.japhpi.2023.100005","DOIUrl":"10.1016/j.japhpi.2023.100005","url":null,"abstract":"<div><p>This commentary discusses the role of ambulatory care pharmacists in diabetes care and the evolving use of continuous glucose monitoring (CGM) technology. As the clinical burden and costs related to care for diabetes grows, ambulatory care pharmacists are uniquely positioned to realize the potential of and implement technology in the patient care process. Although previous technologies often focused on phone-based interventions, rapidly evolving technology, such as CGM, offers great insight related to disease state management. Despite the growth of CGM technology, there is still limited recognition of the value of pharmacists in the utilization of diabetes technology. Ambulatory care pharmacists have the appropriate resources and training to navigate barriers and support effective use of CGMs. They can provide guidance in selecting the best device based on patient-specific needs and accessibility. Pharmacists can also educate patients on how to use devices, interpret data, and integrate it with mobile applications for monitoring and data sharing. In addition, pharmacists can assist in ongoing management by reviewing data reports and making necessary adjustments to therapy. Pharmacist-led education and multidisciplinary coordination can support integration of CGMs in clinical settings. Pharmacists can deliver in-service education, provide clinical support to administrative workflow related to care, and provide consultations to increase provider comfort in prescribing CGMs. Pharmacists’ potential with CGM and diabetes technology in primary care would be best realized through better characterization of pharmacists’ interventions in diabetes care, increased recognition of their role on the interprofessional team, and describing viable reimbursement pathways available to pharmacists. This article describes how pharmacists in ambulatory care can use CGM as an example of diabetes technology to improve patient care through a patient case. A call to action is provided for further education, research, and support for pharmacists leveraging technology in these roles.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 1","pages":"Article 100005"},"PeriodicalIF":0.0,"publicationDate":"2023-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969023000052/pdfft?md5=45b928746092ec59efa3e51d54340f2b&pid=1-s2.0-S2949969023000052-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135564805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Scaling the optimizing care model in community pharmacy using implementation mapping and COM-B theoretical frameworks","authors":"Kenneth C. Hohmeier,&nbsp;Kea Turner,&nbsp;Michael Harland,&nbsp;Kelsey Frederick,&nbsp;Leanne Rein,&nbsp;Daniel Atchley,&nbsp;Ashley Woodyard,&nbsp;Valerie Wasem,&nbsp;Shane Desselle","doi":"10.1016/j.japhpi.2023.100002","DOIUrl":"10.1016/j.japhpi.2023.100002","url":null,"abstract":"<div><h3>Background</h3><p>There has been increasing evidence that “task shifting,” when a provider entrusting specific responsibilities to another member of their team, can increase care access and may lead to better patient care outcomes. This has been particularly underscored in underserved communities throughout the world where task shifting has led to increased health care access in areas of provider shortages. Within the profession of pharmacy, pharmacy technicians are the primary pharmacist assistants and recipients of pharmacist-delegated tasks. Recently, such task delegation has placed the pharmacist in more direct patient care responsibilities beyond medication dispensing—and one such model with a growing evidence base is the optimizing care model. The optimizing care model is an novel approach to community pharmacy practice centered on expanded clinical service delivery by means of task delegation. Through task shifting, the optimizing care model has been shown to reduce medication errors and increase the quantity of patient care services offered by the pharmacist. However, means to spread and scale the model have yet to be reported in the literature.</p></div><div><h3>Methods</h3><p>This article describes the development of a package of implementation strategies designed to facilitate implementation of the optimizing care model in a single division of nationwide supermarket pharmacy chain. The implementation mapping approach was used to systematically develop strategies. In this approach, a protocol is prospectively developed to guide the implementation of a novel evidence-based interventions into a given setting, including the development of implementation strategies.</p></div><div><h3>Results</h3><p>The application of the 5 steps of implementation mapping is described in detail. Implementation objectives, models, and strategies are outlined, as well as the final implementation protocol. There was an overall increase in weeks meeting the 10% optimizing care model threshold—33% at baseline to 83% after the intervention.</p></div><div><h3>Conclusions</h3><p>The implementation mapping process led to development of multifaceted implementation strategy for implementing the optimizing care model into community pharmacy practice. The strategy improved optimizing care model implementation. Further research is needed to understand which strategies were most impactful.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 1","pages":"Article 100002"},"PeriodicalIF":0.0,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969023000027/pdfft?md5=462af70b30ea8c769ba0ee684a3fa36f&pid=1-s2.0-S2949969023000027-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135762815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A new framework for elevating and updating clinical language: RAISED patient-centric communication","authors":"K. Ashley Garling,&nbsp;Morgan P. Stewart","doi":"10.1016/j.japhpi.2023.100001","DOIUrl":"10.1016/j.japhpi.2023.100001","url":null,"abstract":"<div><p>Patient-centered care has been a key priority in health care for the last decade. However, successful execution of patient-centered care is dependent on health care team self-awareness and effective communication skills. Team awareness and communication are essential between health care providers across all communication modalities within the health care system. Patient-centric communication places the needs, wants, preferences, and motivations of the patient foremost to create an overall open, receptive, and honest patient-provider encounter. To best provide patient-centric communication in all patient-provider interactions, we propose a new communication framework: “Recognition, Awareness, Inclusivity, Stigma-free, and making patient-centric Educated Decisions” (RAISED). This communication framework encompasses techniques and strategies that can be used by any health care providers with any patient encounter through in-person, telehealth, verbal, or written modalities. The purpose of using the RAISED framework in practice is to improve patient-centric communication skills through stigma-free and inclusive language during shared decision making, resulting in improved patient satisfaction and health outcomes.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 1","pages":"Article 100001"},"PeriodicalIF":0.0,"publicationDate":"2023-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969023000015/pdfft?md5=9cc3a8ca591c945c43dcdf6213f2e947&pid=1-s2.0-S2949969023000015-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135762544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}